Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2020 Financial Results And Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. META
4. ABBV
5. SPY
6. ACN
7. IBM
8. NKE
9. MU
10. AWK

Go back to Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2020 Financial Results And Provides Corporate Update

Intra-Cellular Therapies (ITCI) Tops Q4 EPS by 9c, Revenues Beat

February 25, 2021 7:47 AM EST

Intra-Cellular Therapies (NASDAQ: ITCI) reported Q4 EPS of ($0.76), $0.09 better than the analyst estimate of ($0.85). Revenue for the quarter came in at $12.45 million versus the consensus estimate of $11.84 million.

2020 was a transformational year for our company with the launch of our first product,... More